State of the art: diagnostic tools and innovative therapies for treatment of advanced thymoma and thymic carcinoma
Authors:
- 15 December 2015
- journal article
- review article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 49 (6) , 1545-1552
Abstract
In this review article, state-of-the-art diagnostic tools and innovative treatments of thymoma and thymic carcinoma (TC) are described with special respect to advanced tumour stages. Complete surgical resection (R0) remains the standard therapeutic approach for almost all a priori resectable mediastinal tumours as defined by preoperative standard computed tomography (CT). If lymphoma or germ-cell tumours are differential diagnostic considerations, biopsy may be indicated. Resection status is the most important prognostic factor in thymoma and TC, followed by tumour stage. Advanced (Masaoka-Koga stage III and IVa) tumours require interdisciplinary therapy decisions based on distinctive findings of preoperative CT scan and ancillary investigations [magnetic resonance imaging (MRI)] to select cases for primary surgery or neoadjuvant strategies with optional secondary resection. In neoadjuvant settings, octreotide scans and histological evaluation of pretherapeutic needle biopsies may help to choose between somatostatin agonist/prednisolone regimens and neoadjuvant chemotherapy as first-line treatment. Finally, a multimodality treatment regime is recommended for advanced and unresectable thymic tumours. In conclusion, advanced stage thymoma and TC should preferably be treated in experienced centres in order to provide all modern diagnostic tools (imaging, histology) and innovative therapy techniques. Systemic and local (hyperthermic intrathoracic chemotherapy) medical treatments together with extended surgical resections have increased the therapeutic options in patients with advanced or recurrent thymoma and TC.Keywords
This publication has 73 references indexed in Scilit:
- The Impact of Thymoma Histotype on Prognosis in a Worldwide DatabaseJournal of Thoracic Oncology, 2015
- Development of the International Thymic Malignancy Interest Group International Database: An Unprecedented Resource for the Study of a Rare Group of TumorsJournal of Thoracic Oncology, 2014
- ITMIG Consensus Statement on the Use of the WHO Histological Classification of Thymoma and Thymic Carcinoma: Refined Definitions, Histological Criteria, and ReportingJournal of Thoracic Oncology, 2014
- The Masaoka-Koga Stage Classification for Thymic Malignancies: Clarification and Definition of TermsJournal of Thoracic Oncology, 2011
- Masaoka Stage and Histologic Grade Predict Prognosis in Patients With Thymic CarcinomaThe Annals of Thoracic Surgery, 2010
- Thymic tumorsThe Annals of Thoracic Surgery, 2004
- Tumor Recurrence and Survival in Patients Treated for Thymomas and Thymic Squamous Cell Carcinomas: A Retrospective AnalysisJournal of Clinical Oncology, 2004
- On the Histologic Heterogeneity of Thymic Epithelial NeoplasmsAmerican Journal of Clinical Pathology, 2000
- Thymoma: State of the ArtJournal of Clinical Oncology, 1999
- A review of 79 thymomas: Modification of staging system and reappraisal of conventional division into invasive and non‐invasive thymomaPathology International, 1994